Literature DB >> 8393209

Potential viral vectors for the stimulation of mucosal antibody responses against enteric viral antigens in pigs.

T Tuboly1, E Nagy, J B Derbyshire.   

Abstract

Four viruses were compared for their ability to induce an intestinal antibody response in piglets. Antibodies were not detected in response to oral vaccination with either fowlpox virus or a baculovirus (BV). Simultaneous oral dosing and parenteral inoculation with high concentrations of BV in an oil emulsion adjuvant induced high levels of circulating virus neutralising (VN) antibodies, and also low levels of intestinal antibodies when booster doses of virus were given. In response to oral vaccination with swinepox virus (SPV), low levels of circulating and intestinal VN antibodies, and higher titres of antibodies reactive in an enzyme immunoassay, including intestinal antibodies of the IgA class, were detected. Oral vaccination with porcine adenovirus type 3 (PAV-3) stimulated both circulating and intestinal VN antibodies, and IgA antibodies were demonstrated in the intestinal contents. It was concluded that SPV and PAV-3 might be suitable vectors for the expression of genes encoding the protective antigens of porcine enteric viruses.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8393209      PMCID: PMC7131402          DOI: 10.1016/0034-5288(93)90133-z

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  20 in total

1.  Experimental swine pox.

Authors:  L KASZA; R A GRIESEMER
Journal:  Am J Vet Res       Date:  1962-05       Impact factor: 1.156

2.  Effect of circulating, maternally derived antibody on the development of a local immune response in the intestine of the neonatal pig.

Authors:  D L Watson; M A Bennell; T D Chaniago
Journal:  Am J Vet Res       Date:  1979-01       Impact factor: 1.156

3.  Vaccination of 1-day-old chicks with fowlpox virus by the aerosol, drinking water, or cutaneous routes.

Authors:  E Nagy; A D Maeda-Machang'u; P J Krell; J B Derbyshire
Journal:  Avian Dis       Date:  1990 Jul-Sep       Impact factor: 1.577

4.  Primary structure of the S peplomer gene of bovine coronavirus and surface expression in insect cells.

Authors:  M D Parker; D Yoo; G J Cox; L A Babiuk
Journal:  J Gen Virol       Date:  1990-02       Impact factor: 3.891

5.  Four sporadic cases of congenital swinepox.

Authors:  G H Borst; T G Kimman; A L Gielkens; J S van der Kamp
Journal:  Vet Rec       Date:  1990-07-21       Impact factor: 2.695

6.  A recombinant fowlpox virus expressing the hemagglutinin-neuraminidase gene of Newcastle disease virus (NDV) protects chickens against challenge by NDV.

Authors:  M E Boursnell; P F Green; A C Samson; J I Campbell; A Deuter; R W Peters; N S Millar; P T Emmerson; M M Binns
Journal:  Virology       Date:  1990-09       Impact factor: 3.616

7.  Comparison of inactivated Newcastle disease viral vaccines containing different emulsion adjuvants.

Authors:  M Brugh; H D Stone; H W Lupton
Journal:  Am J Vet Res       Date:  1983-01       Impact factor: 1.156

8.  Recombinant fowlpox virus inducing protective immunity in non-avian species.

Authors:  J Taylor; R Weinberg; B Languet; P Desmettre; E Paoletti
Journal:  Vaccine       Date:  1988-12       Impact factor: 3.641

9.  Swine pox in Nigeria.

Authors:  B E Olufemi; G O Ayoade; B O Ikede; S O Akpavie; K J Nwufoh
Journal:  Vet Rec       Date:  1981-09-26       Impact factor: 2.695

10.  Adenovirus enteritis in pigs.

Authors:  W Coussement; R Ducatelle; G Charlier; J Hoorens
Journal:  Am J Vet Res       Date:  1981-11       Impact factor: 1.156

View more
  11 in total

1.  Characterization of early region 4 of porcine adenovirus serotype 5.

Authors:  T Tuboly; M Nagy; E Nagy
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

2.  Molecular cloning and physical mapping of porcine adenovirus types 1 and 2.

Authors:  P S Reddy; T Tuboly; E Nagy; J B Derbyshire
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

3.  Passive protection of piglets by recombinant baculovirus induced transmissible gastroenteritis virus specific antibodies.

Authors:  T Tuboly; E Nagy; J B Derbyshire
Journal:  Can J Vet Res       Date:  1995-01       Impact factor: 1.310

4.  Oral Biologic Delivery: Advances Toward Oral Subunit, DNA, and mRNA Vaccines and the Potential for Mass Vaccination During Pandemics.

Authors:  Jacob William Coffey; Gaurav Das Gaiha; Giovanni Traverso
Journal:  Annu Rev Pharmacol Toxicol       Date:  2020-08-31       Impact factor: 13.820

5.  Immunogenicity of the S protein of transmissible gastroenteritis virus expressed in baculovirus.

Authors:  T Tuboly; E Nagy; J R Dennis; J B Derbyshire
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

Review 6.  Circumventing antivector immunity: potential use of nonhuman adenoviral vectors.

Authors:  Estrella Lopez-Gordo; Iva I Podgorski; Nicholas Downes; Ramon Alemany
Journal:  Hum Gene Ther       Date:  2014-03-25       Impact factor: 5.695

Review 7.  Development of nonhuman adenoviruses as vaccine vectors.

Authors:  Dinesh S Bangari; Suresh K Mittal
Journal:  Vaccine       Date:  2005-09-23       Impact factor: 3.641

Review 8.  Swinepox virus as a vaccine vector for swine pathogens.

Authors:  D N Tripathy
Journal:  Adv Vet Med       Date:  1999

Review 9.  Porcine adenovirus as a delivery system for swine vaccines and immunotherapeutics.

Authors:  Jef M Hammond; Michael A Johnson
Journal:  Vet J       Date:  2005-01       Impact factor: 2.688

Review 10.  Vaccines for viral and parasitic diseases produced with baculovirus vectors.

Authors:  Monique M van Oers
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.